jim cramer eli lilly glp-1 Urges Novo Nordisk (NYSE: NVO) To Beat (NYSE: LLY) In The Market Rather Than The Courtroom GLP-1 (S) peptide Select Pack Size::6 Bottles Excellus BlueCross BlueShield is

jim cramer eli lilly glp-1 Urges Novo Nordisk (NYSE: NVO) To Beat (NYSE: LLY) In The Market Rather Than The Courtroom GLP-1 (S) peptide Select Pack Size::6 Bottles Excellus BlueCross BlueShield is

Excellus BlueCross BlueShield is clarifying coverage of GLP-1 medications. GLP-1s prescribed for diabetes remain covered. For weight loss drugs like Wegovy, Zepbound and Saxenda, coverage will change in 2026, with exceptions available

The median weight change was also comparable among the insulin regimens ranging between -0.4 – 0.8 kg

GLP-1 (S) peptide

Select Pack Size::6 Bottles

And most importantly, all studies used oral supplementation